 |
|
What is the IQ2 of your ADMET assay?
Watch this 20 minute video presentation to learn how good modelling practises can be applied to your ADMET assays. It touches on three core elements of good models:
1. Models that allow Integration of data/results/different assays
2. Models that are Quantitative in nature, like dose-response models
3. Models that are decision making focused (the 'squared' on IQ)
Webinar of the month
Every month we select the hottest webinar in the field of drug discovery ADMET. This month we have chosen a webinar organised by the Drug Safey Executive Council (DSEC) with the title 'Transitioning New Safety Biomarkers into Routine IND Enabling Studies and Early Development'. The webinar was moderated by Dr. Jack Reynolds, Chairman of the DSEC Advisory Board, and featured the following industry panelists:
- Dr. Darrell Abernethy, Associate Director for Drug Safety, Office of Clinical Pharmacology, FDA
- Dr. Ernie Bush, Vice President, Collaborative Projects, DSEC
- Dr. Elizabeth Gribble Walker, Director, Predictive Safety Testing Consortium, Critical Path Institute
- Dr. Tanja Zabka, Global Safety Biomarker Lead, Senior Veterinary Pathologist, Roche
You can access this on-demand webinar on DSEC's website:
Are you going to the 50th annual SOT event between 6-10 March?
Learn how the combination of both functional genomics and high content screening might contribute to the development of better toxicology modelling tools and ultimately better early stage decision-making.
Date: Wednesday, March 9
Time: 2:15 PM-3:15 PM
Venue: Walter E. Washington Convention Center, Washington DC
Room Assignment: 140A
Please visit SimuGen's booth (#1026) in the SOT exhibition hall and find out how you can win a brand new Google Android tablet.
|
|
|
